isf 2405 has been researched along with cadralazine in 7 studies
| Studies (isf 2405) | Trials (isf 2405) | Recent Studies (post-2010) (isf 2405) | Studies (cadralazine) | Trials (cadralazine) | Recent Studies (post-2010) (cadralazine) |
|---|---|---|---|---|---|
| 9 | 1 | 0 | 80 | 16 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nässberger, L | 1 |
| Andersson, M; Dahlbäck, B; Englund, G; Hanson, A | 1 |
| Brunel, P; Guyene, TT; Imhof, P; Lecaillon, JB; Ménard, J | 1 |
| Inukai, T; Karaki, H; Mitsui, M; Nakao, K | 1 |
| Hashimoto, M; Hayashi, T; Ishikawa, S; Sekine, Y; Takeyama, K; Terauchi, Y; Watari, S | 1 |
| Higashio, T; Kuroda, K | 1 |
| Hashimoto, M; Ishikawa, S; Kagemoto, A; Nakao, M; Negoro, T; Sekine, Y; Terauchi, Y; Watari, S | 1 |
1 trial(s) available for isf 2405 and cadralazine
| Article | Year |
|---|---|
Influence of acetylator status on the haemodynamic effects and pharmacokinetics of cadralazine in healthy subjects.
Topics: Acetylation; Adult; Antihypertensive Agents; Blood Pressure; Forearm; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Phenotype; Pyridazines; Regional Blood Flow; Renin; Stroke Volume; Vasodilation | 1990 |
6 other study(ies) available for isf 2405 and cadralazine
| Article | Year |
|---|---|
The antihypertensive compounds hydralazine, dihydralazine and cadralazine and their metabolites inhibit myeloperoxidase activity as measured by chemiluminescence.
Topics: Antihypertensive Agents; Binding Sites; Dihydralazine; Dose-Response Relationship, Drug; Hydralazine; Luminescent Measurements; Magnetic Resonance Spectroscopy; Peroxidase; Pyridazines; Structure-Activity Relationship | 1991 |
Inhibition of complement components C3 and C4 by cadralazine and its active metabolite.
Topics: Antihypertensive Agents; Complement C3; Complement C4; Dihydralazine; Humans; Hydralazine; Hydroxylamine; Hydroxylamines; Procainamide; Pyridazines; Vasodilator Agents | 1991 |
Inhibitory effects of cadralazine and its metabolite, ISF-2405, on contractions and the level of cytosolic Ca2+ in vascular smooth muscle.
Topics: Animals; Calcium; Cytosol; Dinoprost; Dogs; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium; Pyridazines; Rabbits; Vasodilator Agents; Verapamil | 1990 |
Pharmacokinetics of an active cadralazine metabolite in plasma and blood vessels of spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Blood Vessels; Half-Life; Male; Pyridazines; Rats; Rats, Inbred SHR; Vasodilator Agents | 1988 |
Effects of cadralazine on contractions induced by Ca2+ and norepinephrine in isolated rabbit aortic strips.
Topics: Animals; Aorta, Abdominal; Calcium; Hydralazine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Pyridazines; Rabbits | 1988 |
Determination of ISF-2405, an active metabolite of cadralazine, in plasma and tissues by radioimmunoassay.
Topics: Animals; Antibodies; Aorta; Guinea Pigs; Male; Pyridazines; Radioimmunoassay; Rats; Rats, Inbred Strains; Time Factors; Tissue Distribution | 1987 |